Autori: Reck M
| Naslov | Whole exome sequencing (WES) analyses from IMpower133 and 6-year (y) overall survival (OS) from IMbrella A in patients (pts) with extensive-stage small cell lung cancer (ESSCLC) treated with atezolizumab (atezo) (Meeting Abstract) |
| Autori | Kao SCH Reck M Liu SV Dziadziuszko R Hochmair MJ Huemer F Gilberto de Castro J Bernabe Caro R Kim SH Kowalski DM Andric Zoran G  Oancea M Kaul M Li H Danner B Lee MC Nabet BY Sugawara S
|
| Info | ANNALS OF ONCOLOGY, (2024), vol. 35 br. , Suppl. 4, str. S1638-S1638 |
| Projekat | F. Hoffmann-La Roche, Ltd. |
| Ispravka | Web of Science Članak Elečas Rang časopisa Citati: Web of Science |
     |
| Naslov | Avelumab vs Chemotherapy for First-line Treatment of Advanced PD-L1+NSCLC: Primary Analysis from JAVELIN Lung 100 (Meeting Abstract) |
| Autori | Reck M ... Andric Zoran G ... (broj koautora 19)
|
| Info | JOURNAL OF THORACIC ONCOLOGY, (2022), vol. 17 br. 9, Suppl. S, str. S39-S39 |
| Ispravka | Web of Science Elečas Rang časopisa Citati: Web of Science |
|
|
| Naslov | Erlotinib in patients with advanced non-small-cell lung cancer (NSCLC): interim results from the European subpopulation of the open-label TRUST study (Meeting Abstract) |
| Autori | Smit E Reck M Krzakowski M Gridelli C Curescu S Berzinec Peter Barata F McDermott R Jovanovic D Magyarlo P |
| Info | EJC SUPPLEMENTS, (2007), vol. 5 br. 4 , Suppl. , str. 359 -359 |
| Ispravka | Web of Science Članak Elečas Rang časopisa Citati: Web of Science |
|
|
